0001793334-19-000001.txt : 20191220 0001793334-19-000001.hdr.sgml : 20191220 20191220161540 ACCESSION NUMBER: 0001793334-19-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20191220 DATE AS OF CHANGE: 20191220 EFFECTIVENESS DATE: 20191220 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Aniluxx Biotechnology, Inc. CENTRAL INDEX KEY: 0001793334 IRS NUMBER: 833162196 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-356161 FILM NUMBER: 191301636 BUSINESS ADDRESS: STREET 1: 304 NOTTINGHAM DRIVE CITY: CHAPEL HILL STATE: NC ZIP: 27517 BUSINESS PHONE: 561-322-0170 MAIL ADDRESS: STREET 1: 304 NOTTINGHAM DRIVE CITY: CHAPEL HILL STATE: NC ZIP: 27517 D 1 primary_doc.xml X0708 D LIVE 0001793334 Aniluxx Biotechnology, Inc. 304 NOTTINGHAM DRIVE CHAPEL HILL NC NORTH CAROLINA 27517 561-322-0170 DELAWARE None None Corporation true 2019 Stefan C. Weiss 304 Nottingham Drive Chapel Hill NC NORTH CAROLINA 27517 Executive Officer Director Promoter Other Health Care Decline to Disclose 06b false 2019-12-09 false true true true false 0 750000 200000 550000 false 2 0 0 0 true Proceeds will be used for working capital which may include normal compensation to executive officers. false Aniluxx Biotechnology, Inc. Stefan C. Weiss Stefan C. Weiss President and CEO 2019-12-20